Unmodified official OCDS data retained by Tenderline for this procurement process.
Complete current OCDS release JSON
{
"id": "014374-2025",
"tag": [
"planning"
],
"date": "2025-04-10T16:10:55+01:00",
"ocid": "ocds-h6vhtk-0500cd",
"buyer": {
"id": "GB-NHS-QMF",
"name": "NHS North East London Integrated Care Board"
},
"tender": {
"id": "PRJ-2149",
"lots": [
{
"id": "1",
"status": "planned",
"description": "NHS NEL ICB is in the process of re-commissioning a new Community Anticoagulation Services. \nThis Prior Information Notice (PIN) serves as the intention to follow the Most Suitable Provider (MSP) process.\nWe are not required to actively invite anyone to express interest but rather seek to notify the market of the intention.\nThe PIN outlines the scope, key service features, criteria, and expectations for providers interested in bidding when the opportunity becomes available.\nFurther details, including procurement timelines and engagement opportunities, will be communicated in due course. \nInterested providers are encouraged to express their interest and stay informed about the process.\nFor enquiries or to register interest, please contact hub.queries@nhs.net\nPatients will be referred to the service from;\n•\tGeneral Practice \n•\tSecondary Care- including patients whose anticoagulation therapy has been previously initiated and managed by acute services.\nThe specification requires the provider to deliver : \n1.\tWarfarin initiation and stablisation for Non-Valvular Atrial Fibrillation (NVAF).\n2.\tWarfarin monitoring and maintenance dose adjustments for patients established on warfarin.\n3.\tDirect Oral Anticoagulant (DOAC) initiation for NVAF, followed by transfer of care to patient's registered GP. \n4.\tSwitching from warfarin to DOAC for NVAF, followed by transfer to patient's GP\n5.\tThe management of excursions from target INR. This is to be in consultation with secondary care specialists when the initiation of treatments to mitigate the impact of under or over anticoagulation with warfarin is necessary. \n6.\tSwitching suitable patients from warfarin to DOAC for NVAF, followed by transfer to patient's registered GP.\n7.\tWhere necessary, escalation of complex patients to secondary care specialists, with referral back to secondary care for ongoing monitoring, to be decided on a case-by-case basis. \n8.\tDomiciliary visits where patient fits the criteria. Additional information: The anticoagulation service provider will be responsible for ensuring that the service is provided according to the service specification. The key aspects of the service specification providers must meet are;\n•\tProvision of a community-based anticoagulant management and monitoring service that is clinically appropriate, cost effective and in line with guidance from NICE, the British Committee for Standards in Haematology and recommendations from the 2007 National Patient Safety Agency Alert: Safer use of anticoagulants. \n•\tTo have a designated named clinical lead responsible for the safe and effective delivery of the commissioned service.\n•\tTo ensure all staff working in the service have the necessary knowledge, skills, competencies and access to ongoing training, as set out by the service specification, in order to meet the requirements of their role. \n•\tTo have a range of standard operating procedures in place to cover the key tasks and patient interventions underpinning the service. \n•\tTo ensure the service is accessible in terms of location and opening hours.\n•\tTo offer the service in a one-stop clinic offering patient education, anticoagulant treatment discussions INR testing, and drug/dose changes in the same consultation. \n•\tTo ensure each interaction, whether a routine visit or a warfarin annual review , is recorded in a standardised template which will be made accessible in the patient's registered GP record. \n•\tTo have a clear escalation process for clinical queries depending on the nature and urgency of the query, including establishing working relationships with secondary care.\n•\tTo report all Serious Incidents and Never Events in accordance with the requirements of relevant Frameworks. \n•\tTo run the service with all appropriate Quality Control processes for point of care testing equipment and materials.\n•\tTo safely manage, document and communicate the cessation of anticoagulation as advised by the specialist.\n•\tTo report in a timely manner all relevant KPIs and financial data as indicated in the specification.\n•\tTo ensure appropriate communication of patient care with the patient's GP (if the service provider is different), community pharmacy, care home (if relevant) and the appropriate secondary care anticoagulation service, if needed."
}
],
"items": [
{
"id": "1",
"relatedLot": "1",
"deliveryLocation": {
"description": "North East London"
},
"deliveryAddresses": [
{
"region": "UKI"
}
]
}
],
"title": "NHS Community Anticoagulation Services",
"status": "planned",
"coveredBy": [
"GPA"
],
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"description": "NHS NEL ICB is in the process of re-commissioning a new Community Anticoagulation Services. This Prior Information Notice (PIN) serves as the intention to follow the Most Suitable Provider (MSP) process.\nWe are not required to actively invite anyone to express interest but rather seek to notify the market of the intention.\nThe PIN outlines the scope, key service features, criteria, and expectations for providers interested in bidding when the opportunity becomes available.\nFurther details, including procurement timelines and engagement opportunities, will be communicated in due course. \nInterested providers are encouraged to express their interest and stay informed about the process.\nFor enquiries or to register interest, please contact hub.queries@nhs.net using reference number PRJ-2149",
"communication": {
"futureNoticeDate": "2025-05-30T00:00:00+01:00"
},
"classification": {
"id": "85140000",
"scheme": "CPV",
"description": "Miscellaneous health services"
},
"mainProcurementCategory": "services"
},
"parties": [
{
"id": "GB-NHS-QMF",
"name": "NHS North East London Integrated Care Board",
"roles": [
"buyer"
],
"address": {
"region": "UKI41",
"locality": "London",
"postalCode": "E151DA",
"countryName": "United Kingdom",
"streetAddress": "4th Floor - Unex Tower, 5 Station Street"
},
"details": {
"url": "https://northeastlondon.icb.nhs.uk/",
"classifications": [
{
"id": "BODY_PUBLIC",
"scheme": "TED_CA_TYPE",
"description": "Body governed by public law"
},
{
"id": "07",
"scheme": "COFOG",
"description": "Health"
}
]
},
"identifier": {
"id": "QMF",
"scheme": "GB-NHS",
"legalName": "NHS North East London Integrated Care Board"
},
"contactPoint": {
"email": "hub.queries@nhs.net"
}
}
],
"language": "en",
"initiationType": "tender"
}Complete JSON history (1 releases)
10 Apr 2025 · 014374-2025 · planning
{
"id": "014374-2025",
"tag": [
"planning"
],
"date": "2025-04-10T16:10:55+01:00",
"ocid": "ocds-h6vhtk-0500cd",
"buyer": {
"id": "GB-NHS-QMF",
"name": "NHS North East London Integrated Care Board"
},
"tender": {
"id": "PRJ-2149",
"lots": [
{
"id": "1",
"status": "planned",
"description": "NHS NEL ICB is in the process of re-commissioning a new Community Anticoagulation Services. \nThis Prior Information Notice (PIN) serves as the intention to follow the Most Suitable Provider (MSP) process.\nWe are not required to actively invite anyone to express interest but rather seek to notify the market of the intention.\nThe PIN outlines the scope, key service features, criteria, and expectations for providers interested in bidding when the opportunity becomes available.\nFurther details, including procurement timelines and engagement opportunities, will be communicated in due course. \nInterested providers are encouraged to express their interest and stay informed about the process.\nFor enquiries or to register interest, please contact hub.queries@nhs.net\nPatients will be referred to the service from;\n•\tGeneral Practice \n•\tSecondary Care- including patients whose anticoagulation therapy has been previously initiated and managed by acute services.\nThe specification requires the provider to deliver : \n1.\tWarfarin initiation and stablisation for Non-Valvular Atrial Fibrillation (NVAF).\n2.\tWarfarin monitoring and maintenance dose adjustments for patients established on warfarin.\n3.\tDirect Oral Anticoagulant (DOAC) initiation for NVAF, followed by transfer of care to patient's registered GP. \n4.\tSwitching from warfarin to DOAC for NVAF, followed by transfer to patient's GP\n5.\tThe management of excursions from target INR. This is to be in consultation with secondary care specialists when the initiation of treatments to mitigate the impact of under or over anticoagulation with warfarin is necessary. \n6.\tSwitching suitable patients from warfarin to DOAC for NVAF, followed by transfer to patient's registered GP.\n7.\tWhere necessary, escalation of complex patients to secondary care specialists, with referral back to secondary care for ongoing monitoring, to be decided on a case-by-case basis. \n8.\tDomiciliary visits where patient fits the criteria. Additional information: The anticoagulation service provider will be responsible for ensuring that the service is provided according to the service specification. The key aspects of the service specification providers must meet are;\n•\tProvision of a community-based anticoagulant management and monitoring service that is clinically appropriate, cost effective and in line with guidance from NICE, the British Committee for Standards in Haematology and recommendations from the 2007 National Patient Safety Agency Alert: Safer use of anticoagulants. \n•\tTo have a designated named clinical lead responsible for the safe and effective delivery of the commissioned service.\n•\tTo ensure all staff working in the service have the necessary knowledge, skills, competencies and access to ongoing training, as set out by the service specification, in order to meet the requirements of their role. \n•\tTo have a range of standard operating procedures in place to cover the key tasks and patient interventions underpinning the service. \n•\tTo ensure the service is accessible in terms of location and opening hours.\n•\tTo offer the service in a one-stop clinic offering patient education, anticoagulant treatment discussions INR testing, and drug/dose changes in the same consultation. \n•\tTo ensure each interaction, whether a routine visit or a warfarin annual review , is recorded in a standardised template which will be made accessible in the patient's registered GP record. \n•\tTo have a clear escalation process for clinical queries depending on the nature and urgency of the query, including establishing working relationships with secondary care.\n•\tTo report all Serious Incidents and Never Events in accordance with the requirements of relevant Frameworks. \n•\tTo run the service with all appropriate Quality Control processes for point of care testing equipment and materials.\n•\tTo safely manage, document and communicate the cessation of anticoagulation as advised by the specialist.\n•\tTo report in a timely manner all relevant KPIs and financial data as indicated in the specification.\n•\tTo ensure appropriate communication of patient care with the patient's GP (if the service provider is different), community pharmacy, care home (if relevant) and the appropriate secondary care anticoagulation service, if needed."
}
],
"items": [
{
"id": "1",
"relatedLot": "1",
"deliveryLocation": {
"description": "North East London"
},
"deliveryAddresses": [
{
"region": "UKI"
}
]
}
],
"title": "NHS Community Anticoagulation Services",
"status": "planned",
"coveredBy": [
"GPA"
],
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"description": "NHS NEL ICB is in the process of re-commissioning a new Community Anticoagulation Services. This Prior Information Notice (PIN) serves as the intention to follow the Most Suitable Provider (MSP) process.\nWe are not required to actively invite anyone to express interest but rather seek to notify the market of the intention.\nThe PIN outlines the scope, key service features, criteria, and expectations for providers interested in bidding when the opportunity becomes available.\nFurther details, including procurement timelines and engagement opportunities, will be communicated in due course. \nInterested providers are encouraged to express their interest and stay informed about the process.\nFor enquiries or to register interest, please contact hub.queries@nhs.net using reference number PRJ-2149",
"communication": {
"futureNoticeDate": "2025-05-30T00:00:00+01:00"
},
"classification": {
"id": "85140000",
"scheme": "CPV",
"description": "Miscellaneous health services"
},
"mainProcurementCategory": "services"
},
"parties": [
{
"id": "GB-NHS-QMF",
"name": "NHS North East London Integrated Care Board",
"roles": [
"buyer"
],
"address": {
"region": "UKI41",
"locality": "London",
"postalCode": "E151DA",
"countryName": "United Kingdom",
"streetAddress": "4th Floor - Unex Tower, 5 Station Street"
},
"details": {
"url": "https://northeastlondon.icb.nhs.uk/",
"classifications": [
{
"id": "BODY_PUBLIC",
"scheme": "TED_CA_TYPE",
"description": "Body governed by public law"
},
{
"id": "07",
"scheme": "COFOG",
"description": "Health"
}
]
},
"identifier": {
"id": "QMF",
"scheme": "GB-NHS",
"legalName": "NHS North East London Integrated Care Board"
},
"contactPoint": {
"email": "hub.queries@nhs.net"
}
}
],
"language": "en",
"initiationType": "tender"
}